Jack Volker Greiner, D.O., O.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dry Eye Syndromes | 16 | 2023 | 386 | 2.240 |
Why?
|
| Meibomian Glands | 12 | 2016 | 85 | 1.950 |
Why?
|
| Tears | 19 | 2023 | 256 | 1.910 |
Why?
|
| Glycerylphosphorylcholine | 5 | 2020 | 25 | 1.520 |
Why?
|
| Hyperthermia, Induced | 7 | 2016 | 403 | 1.460 |
Why?
|
| Lens, Crystalline | 21 | 2019 | 388 | 1.410 |
Why?
|
| Eyelid Diseases | 7 | 2016 | 155 | 1.310 |
Why?
|
| Conjunctivitis, Allergic | 8 | 2007 | 130 | 1.260 |
Why?
|
| Adenosine Triphosphate | 19 | 2022 | 2025 | 1.230 |
Why?
|
| Cornea | 23 | 2020 | 1524 | 1.050 |
Why?
|
| Conjunctiva | 23 | 2023 | 494 | 0.960 |
Why?
|
| Phospholipids | 14 | 2022 | 784 | 0.960 |
Why?
|
| Phosphates | 19 | 2022 | 786 | 0.890 |
Why?
|
| Sjogren's Syndrome | 1 | 2023 | 233 | 0.770 |
Why?
|
| Eyelids | 11 | 2011 | 265 | 0.770 |
Why?
|
| Ketotifen | 3 | 2003 | 21 | 0.690 |
Why?
|
| Endothelium, Corneal | 6 | 2020 | 199 | 0.680 |
Why?
|
| Phosphorus | 14 | 2020 | 338 | 0.660 |
Why?
|
| Cryopreservation | 3 | 2020 | 670 | 0.660 |
Why?
|
| Anti-Allergic Agents | 3 | 2005 | 141 | 0.650 |
Why?
|
| Magnetic Resonance Spectroscopy | 44 | 2020 | 3760 | 0.650 |
Why?
|
| Dibenzoxepins | 4 | 2007 | 28 | 0.640 |
Why?
|
| Corneal Dystrophy, Juvenile Epithelial of Meesmann | 1 | 2017 | 1 | 0.620 |
Why?
|
| Photorefractive Keratectomy | 1 | 2017 | 38 | 0.590 |
Why?
|
| Lasers, Excimer | 1 | 2017 | 72 | 0.580 |
Why?
|
| Rabbits | 29 | 2020 | 4894 | 0.580 |
Why?
|
| Corneal Transplantation | 5 | 2020 | 386 | 0.570 |
Why?
|
| Retina | 9 | 2022 | 2616 | 0.560 |
Why?
|
| Epithelium, Corneal | 2 | 2017 | 247 | 0.540 |
Why?
|
| Lipid Metabolism | 9 | 2019 | 1889 | 0.520 |
Why?
|
| Fluorescein | 8 | 2010 | 171 | 0.520 |
Why?
|
| Hydrocortisone | 1 | 2022 | 1826 | 0.490 |
Why?
|
| Histamine H1 Antagonists | 2 | 2004 | 100 | 0.470 |
Why?
|
| Ophthalmic Solutions | 10 | 2007 | 317 | 0.450 |
Why?
|
| Glucocorticoids | 1 | 2022 | 2107 | 0.440 |
Why?
|
| Contact Lenses | 16 | 1999 | 145 | 0.420 |
Why?
|
| Organophosphorus Compounds | 8 | 1991 | 215 | 0.400 |
Why?
|
| Patient Discharge | 1 | 2021 | 3313 | 0.310 |
Why?
|
| Conjunctivitis | 12 | 1985 | 158 | 0.310 |
Why?
|
| Pandemics | 5 | 2021 | 8388 | 0.300 |
Why?
|
| Membrane Lipids | 5 | 1995 | 248 | 0.300 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2021 | 253 | 0.300 |
Why?
|
| Osmolar Concentration | 3 | 2023 | 683 | 0.290 |
Why?
|
| Bandages | 3 | 2008 | 266 | 0.280 |
Why?
|
| Nedocromil | 2 | 2003 | 46 | 0.280 |
Why?
|
| Pheniramine | 1 | 2005 | 1 | 0.270 |
Why?
|
| Naphazoline | 1 | 2005 | 7 | 0.270 |
Why?
|
| Eye | 3 | 2002 | 729 | 0.260 |
Why?
|
| Phosphorus Isotopes | 10 | 1998 | 126 | 0.260 |
Why?
|
| Eye Banks | 4 | 1997 | 38 | 0.250 |
Why?
|
| Energy Metabolism | 8 | 2022 | 2899 | 0.250 |
Why?
|
| Contact Lenses, Hydrophilic | 10 | 2002 | 64 | 0.250 |
Why?
|
| Epithelium | 17 | 2011 | 1679 | 0.240 |
Why?
|
| Phosphatidylglycerols | 1 | 2022 | 34 | 0.220 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2003 | 99 | 0.220 |
Why?
|
| Conjunctival Diseases | 6 | 2005 | 122 | 0.210 |
Why?
|
| Blepharitis | 2 | 1999 | 36 | 0.210 |
Why?
|
| Cell Count | 7 | 2020 | 1856 | 0.210 |
Why?
|
| Adaptation, Ocular | 1 | 2022 | 93 | 0.210 |
Why?
|
| Cromolyn Sodium | 1 | 2002 | 87 | 0.210 |
Why?
|
| Plant Oils | 1 | 2022 | 202 | 0.200 |
Why?
|
| Guanosine Triphosphate | 1 | 2022 | 321 | 0.200 |
Why?
|
| Phosphatidylinositols | 1 | 2022 | 291 | 0.200 |
Why?
|
| Dark Adaptation | 1 | 2022 | 219 | 0.200 |
Why?
|
| Phosphatidylserines | 1 | 2022 | 193 | 0.200 |
Why?
|
| Blinking | 2 | 2007 | 138 | 0.190 |
Why?
|
| Administration, Cutaneous | 1 | 2022 | 711 | 0.180 |
Why?
|
| Cataract | 5 | 2019 | 834 | 0.180 |
Why?
|
| Nursing Staff | 1 | 2021 | 129 | 0.180 |
Why?
|
| Massage | 2 | 1997 | 85 | 0.180 |
Why?
|
| Sulfacetamide | 1 | 1999 | 3 | 0.180 |
Why?
|
| Contrast Media | 4 | 2005 | 5300 | 0.170 |
Why?
|
| Organ Preservation Solutions | 1 | 2020 | 98 | 0.170 |
Why?
|
| Animals | 54 | 2022 | 168757 | 0.170 |
Why?
|
| Safety | 2 | 2020 | 1186 | 0.170 |
Why?
|
| Surface-Active Agents | 1 | 1999 | 159 | 0.160 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 407 | 0.160 |
Why?
|
| Culture Media | 2 | 2020 | 908 | 0.160 |
Why?
|
| Prednisolone | 1 | 1999 | 334 | 0.160 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 712 | 0.160 |
Why?
|
| Diabetic Foot | 1 | 2022 | 355 | 0.160 |
Why?
|
| Ferrets | 5 | 1991 | 194 | 0.150 |
Why?
|
| Phototherapy | 1 | 2020 | 377 | 0.150 |
Why?
|
| Adenosine Diphosphate | 10 | 1993 | 425 | 0.150 |
Why?
|
| Uvea | 2 | 1995 | 31 | 0.150 |
Why?
|
| Humans | 89 | 2023 | 744343 | 0.140 |
Why?
|
| Lens Cortex, Crystalline | 2 | 1994 | 21 | 0.140 |
Why?
|
| Lens Nucleus, Crystalline | 2 | 1994 | 32 | 0.140 |
Why?
|
| Dermis | 1 | 1998 | 207 | 0.140 |
Why?
|
| Double-Blind Method | 9 | 2022 | 12026 | 0.140 |
Why?
|
| Anti-Infective Agents, Local | 1 | 1999 | 250 | 0.140 |
Why?
|
| Lens Capsule, Crystalline | 2 | 1994 | 43 | 0.140 |
Why?
|
| Piperidines | 1 | 2004 | 1602 | 0.140 |
Why?
|
| Education, Distance | 1 | 2020 | 251 | 0.140 |
Why?
|
| Photoreceptor Cells | 5 | 1984 | 244 | 0.130 |
Why?
|
| Visual Acuity | 4 | 2016 | 2530 | 0.130 |
Why?
|
| Lipids | 4 | 2003 | 3305 | 0.130 |
Why?
|
| Epidermis | 1 | 1998 | 528 | 0.130 |
Why?
|
| Triglycerides | 1 | 2022 | 2454 | 0.120 |
Why?
|
| Microscopy, Electron | 12 | 1991 | 2645 | 0.120 |
Why?
|
| Mucus | 5 | 1985 | 321 | 0.120 |
Why?
|
| Emollients | 2 | 2022 | 34 | 0.120 |
Why?
|
| Allergens | 4 | 2007 | 1320 | 0.120 |
Why?
|
| Drug Delivery Systems | 2 | 2002 | 2219 | 0.120 |
Why?
|
| Orbit | 1 | 1997 | 426 | 0.120 |
Why?
|
| Pruritus | 3 | 2007 | 361 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 1855 | 0.110 |
Why?
|
| Adult | 49 | 2017 | 214055 | 0.110 |
Why?
|
| Sugar Phosphates | 6 | 1991 | 41 | 0.110 |
Why?
|
| Choroid | 2 | 1995 | 322 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 10 | 1997 | 2557 | 0.110 |
Why?
|
| Models, Animal | 1 | 2020 | 2171 | 0.110 |
Why?
|
| Carnivora | 2 | 1984 | 29 | 0.110 |
Why?
|
| Cats | 10 | 1994 | 998 | 0.110 |
Why?
|
| Fluorophotometry | 3 | 2019 | 40 | 0.110 |
Why?
|
| Tissue Preservation | 3 | 1994 | 182 | 0.110 |
Why?
|
| Middle Aged | 41 | 2016 | 213383 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3133 | 0.100 |
Why?
|
| Rats | 9 | 2022 | 24260 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3240 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 8 | 1997 | 964 | 0.100 |
Why?
|
| Administration, Topical | 2 | 2005 | 690 | 0.090 |
Why?
|
| Aqueous Humor | 1 | 1991 | 161 | 0.090 |
Why?
|
| Aged | 22 | 2023 | 163280 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 1344 | 0.090 |
Why?
|
| Health Personnel | 2 | 2020 | 3218 | 0.090 |
Why?
|
| Body Temperature | 2 | 2012 | 777 | 0.080 |
Why?
|
| Vitreous Body | 1 | 1991 | 389 | 0.080 |
Why?
|
| Pigment Epithelium of Eye | 6 | 1991 | 220 | 0.080 |
Why?
|
| Body Water | 1 | 1990 | 343 | 0.080 |
Why?
|
| Male | 27 | 2017 | 350118 | 0.080 |
Why?
|
| Keratoconus | 2 | 1989 | 121 | 0.080 |
Why?
|
| Prospective Studies | 8 | 2016 | 53288 | 0.080 |
Why?
|
| Microvilli | 4 | 1982 | 241 | 0.080 |
Why?
|
| Public Health | 1 | 2021 | 2603 | 0.080 |
Why?
|
| Swine | 9 | 1995 | 5917 | 0.080 |
Why?
|
| Dibenzazepines | 1 | 2007 | 26 | 0.080 |
Why?
|
| Verapamil | 1 | 1988 | 244 | 0.080 |
Why?
|
| Corneal Diseases | 4 | 2004 | 636 | 0.070 |
Why?
|
| Eye Foreign Bodies | 1 | 1988 | 55 | 0.070 |
Why?
|
| Drug Combinations | 2 | 2005 | 1959 | 0.070 |
Why?
|
| Refraction, Ocular | 1 | 2007 | 182 | 0.070 |
Why?
|
| Ophthalmology | 1 | 2012 | 508 | 0.070 |
Why?
|
| Recurrence | 1 | 2017 | 8340 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2019 | 63114 | 0.060 |
Why?
|
| Vision, Low | 1 | 2007 | 168 | 0.060 |
Why?
|
| Female | 22 | 2016 | 380194 | 0.060 |
Why?
|
| Dogs | 4 | 1995 | 3912 | 0.060 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 3 | 2004 | 245 | 0.060 |
Why?
|
| Emulsions | 2 | 2022 | 156 | 0.060 |
Why?
|
| Ouabain | 1 | 1985 | 264 | 0.060 |
Why?
|
| Tissue Survival | 1 | 1984 | 118 | 0.060 |
Why?
|
| Guinea Pigs | 3 | 1995 | 1386 | 0.060 |
Why?
|
| Hyperemia | 3 | 2003 | 225 | 0.060 |
Why?
|
| Cricetinae | 3 | 1991 | 2472 | 0.060 |
Why?
|
| Cell Membrane | 5 | 1994 | 3748 | 0.060 |
Why?
|
| Photography | 2 | 1998 | 520 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7279 | 0.060 |
Why?
|
| Tissue Banks | 1 | 1984 | 184 | 0.060 |
Why?
|
| Equipment Design | 1 | 2012 | 3582 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15540 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2012 | 39050 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5751 | 0.060 |
Why?
|
| Cattle | 3 | 1995 | 3922 | 0.060 |
Why?
|
| Centrioles | 1 | 1983 | 79 | 0.050 |
Why?
|
| Keratomileusis, Laser In Situ | 1 | 2004 | 88 | 0.050 |
Why?
|
| Absorption | 1 | 2002 | 248 | 0.050 |
Why?
|
| Paper | 1 | 2002 | 85 | 0.050 |
Why?
|
| Cytoplasmic Granules | 1 | 1985 | 610 | 0.050 |
Why?
|
| Anions | 1 | 2002 | 133 | 0.050 |
Why?
|
| Exocrine Glands | 1 | 1981 | 50 | 0.050 |
Why?
|
| Langerhans Cells | 1 | 1982 | 173 | 0.050 |
Why?
|
| Filtration | 1 | 2002 | 234 | 0.050 |
Why?
|
| Mucins | 1 | 1985 | 564 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7659 | 0.050 |
Why?
|
| Respiratory Protective Devices | 1 | 2021 | 45 | 0.050 |
Why?
|
| Galactose | 1 | 1982 | 306 | 0.050 |
Why?
|
| Optic Nerve | 2 | 1995 | 554 | 0.050 |
Why?
|
| Imidazoles | 1 | 2007 | 1206 | 0.050 |
Why?
|
| Interferometry | 3 | 2009 | 100 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2008 | 10943 | 0.050 |
Why?
|
| Spectrum Analysis | 2 | 1981 | 454 | 0.050 |
Why?
|
| Random Allocation | 2 | 2002 | 2429 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 13989 | 0.040 |
Why?
|
| Sclera | 2 | 1991 | 200 | 0.040 |
Why?
|
| Species Specificity | 3 | 1995 | 2478 | 0.040 |
Why?
|
| Magnesium | 1 | 1983 | 813 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2008 | 2540 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2002 | 1590 | 0.040 |
Why?
|
| Antigens | 2 | 2003 | 1466 | 0.040 |
Why?
|
| Arvicolinae | 2 | 1991 | 22 | 0.040 |
Why?
|
| Cilia | 1 | 1981 | 466 | 0.040 |
Why?
|
| Cautery | 1 | 1998 | 72 | 0.040 |
Why?
|
| Photomicrography | 1 | 1997 | 74 | 0.040 |
Why?
|
| Adolescent | 12 | 2012 | 85781 | 0.040 |
Why?
|
| Reference Values | 2 | 2002 | 4982 | 0.040 |
Why?
|
| Basement Membrane | 2 | 2004 | 356 | 0.040 |
Why?
|
| Mammals | 1 | 1983 | 1143 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2004 | 3144 | 0.040 |
Why?
|
| Organoids | 1 | 1983 | 701 | 0.040 |
Why?
|
| Probability | 1 | 2002 | 2505 | 0.040 |
Why?
|
| Eosinophils | 5 | 1985 | 955 | 0.040 |
Why?
|
| Adenine Nucleotides | 2 | 1989 | 121 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 1995 | 2327 | 0.030 |
Why?
|
| Ultrasonics | 1 | 1977 | 212 | 0.030 |
Why?
|
| Anterior Eye Segment | 1 | 1997 | 152 | 0.030 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1996 | 70 | 0.030 |
Why?
|
| Salmon | 1 | 1995 | 36 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2019 | 638 | 0.030 |
Why?
|
| Cyprinidae | 1 | 1995 | 38 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2008 | 2942 | 0.030 |
Why?
|
| Epithelial Cells | 3 | 2004 | 3690 | 0.030 |
Why?
|
| Humidity | 1 | 1996 | 197 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2019 | 582 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1982 | 1951 | 0.030 |
Why?
|
| Mast Cells | 6 | 1985 | 1544 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 1 | 1994 | 158 | 0.030 |
Why?
|
| Rats, Inbred Strains | 3 | 1985 | 2186 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2008 | 4479 | 0.030 |
Why?
|
| NADP | 2 | 1985 | 226 | 0.030 |
Why?
|
| Ciliary Body | 1 | 1995 | 173 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 4933 | 0.030 |
Why?
|
| Uridine Diphosphate Galactose | 2 | 1984 | 20 | 0.030 |
Why?
|
| Iris | 1 | 1995 | 239 | 0.030 |
Why?
|
| Basophils | 4 | 1979 | 389 | 0.030 |
Why?
|
| Infection Control | 1 | 2021 | 966 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 35421 | 0.030 |
Why?
|
| Rose Bengal | 2 | 2005 | 116 | 0.030 |
Why?
|
| Sheep | 1 | 1995 | 1437 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 875 | 0.030 |
Why?
|
| Gestational Age | 3 | 1991 | 3493 | 0.030 |
Why?
|
| Cryosurgery | 1 | 1977 | 453 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 1997 | 2187 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10481 | 0.030 |
Why?
|
| Time Factors | 8 | 2003 | 40075 | 0.030 |
Why?
|
| Microtubules | 3 | 1982 | 1090 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1996 | 1899 | 0.020 |
Why?
|
| Aging | 4 | 1995 | 8664 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 1994 | 708 | 0.020 |
Why?
|
| Corneal Edema | 1 | 1991 | 52 | 0.020 |
Why?
|
| Lissamine Green Dyes | 1 | 2010 | 2 | 0.020 |
Why?
|
| Lacrimal Apparatus | 2 | 1984 | 225 | 0.020 |
Why?
|
| Staining and Labeling | 2 | 2005 | 1100 | 0.020 |
Why?
|
| Placebos | 2 | 2007 | 1676 | 0.020 |
Why?
|
| NAD | 2 | 1984 | 593 | 0.020 |
Why?
|
| Retinal Ganglion Cells | 1 | 1995 | 770 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 1985 | 1588 | 0.020 |
Why?
|
| Nucleoside Diphosphate Sugars | 1 | 1988 | 8 | 0.020 |
Why?
|
| Dextrans | 2 | 1994 | 595 | 0.020 |
Why?
|
| Light | 2 | 2009 | 1374 | 0.020 |
Why?
|
| Plasma Cells | 4 | 1985 | 591 | 0.020 |
Why?
|
| Papio | 1 | 1989 | 656 | 0.020 |
Why?
|
| Lymphocytes | 3 | 1985 | 2617 | 0.020 |
Why?
|
| Mucous Membrane | 2 | 1981 | 673 | 0.020 |
Why?
|
| Corneal Topography | 1 | 2007 | 69 | 0.020 |
Why?
|
| Phosphatidylethanolamines | 2 | 1990 | 134 | 0.020 |
Why?
|
| Models, Biological | 1 | 2003 | 9583 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14722 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 2029 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2012 | 1270 | 0.020 |
Why?
|
| Color | 1 | 2007 | 307 | 0.020 |
Why?
|
| Lubrication | 1 | 2005 | 20 | 0.020 |
Why?
|
| Wettability | 1 | 2005 | 24 | 0.020 |
Why?
|
| Fluorescent Dyes | 2 | 2005 | 1917 | 0.020 |
Why?
|
| Sialomucins | 1 | 1985 | 17 | 0.020 |
Why?
|
| Uridine Diphosphate Sugars | 1 | 1984 | 10 | 0.020 |
Why?
|
| Phosphorylation | 2 | 1993 | 8436 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 1970 | 0.020 |
Why?
|
| Uridine Diphosphate Glucose | 1 | 1984 | 22 | 0.020 |
Why?
|
| Cadaver | 1 | 1989 | 1337 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2008 | 23403 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13695 | 0.020 |
Why?
|
| Germ-Free Life | 1 | 1984 | 188 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1985 | 719 | 0.010 |
Why?
|
| Corneal Stroma | 1 | 1985 | 174 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 1980 | 2726 | 0.010 |
Why?
|
| Muridae | 1 | 1983 | 61 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2020 | 4558 | 0.010 |
Why?
|
| Papain | 1 | 1983 | 64 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1989 | 2375 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1983 | 252 | 0.010 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2008 | 689 | 0.010 |
Why?
|
| Glycerophosphates | 1 | 1982 | 48 | 0.010 |
Why?
|
| Retinal Pigments | 1 | 1982 | 83 | 0.010 |
Why?
|
| Child | 6 | 2003 | 77709 | 0.010 |
Why?
|
| Endothelium | 1 | 1985 | 778 | 0.010 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2002 | 39 | 0.010 |
Why?
|
| Reagent Strips | 1 | 2001 | 39 | 0.010 |
Why?
|
| Oils | 1 | 2002 | 63 | 0.010 |
Why?
|
| Patient Satisfaction | 2 | 2007 | 3396 | 0.010 |
Why?
|
| Synapses | 2 | 1982 | 1728 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5319 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 1982 | 269 | 0.010 |
Why?
|
| Debridement | 1 | 2004 | 492 | 0.010 |
Why?
|
| Myopia | 1 | 2004 | 254 | 0.010 |
Why?
|
| Half-Life | 1 | 1982 | 661 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1981 | 554 | 0.010 |
Why?
|
| Ions | 1 | 2002 | 265 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1982 | 264 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1984 | 992 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1982 | 964 | 0.010 |
Why?
|
| Papilloma | 1 | 1981 | 148 | 0.010 |
Why?
|
| Conjunctival Neoplasms | 1 | 1981 | 79 | 0.010 |
Why?
|
| Prevalence | 2 | 2010 | 15226 | 0.010 |
Why?
|
| Anesthesia, Local | 1 | 2003 | 275 | 0.010 |
Why?
|
| Choline | 1 | 1982 | 493 | 0.010 |
Why?
|
| Eyelid Neoplasms | 1 | 1981 | 94 | 0.010 |
Why?
|
| Macrophages | 2 | 1985 | 5655 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 1982 | 275 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 1982 | 546 | 0.010 |
Why?
|
| Insulin | 1 | 1994 | 6580 | 0.010 |
Why?
|
| Birefringence | 1 | 1998 | 56 | 0.010 |
Why?
|
| Blister | 1 | 1978 | 86 | 0.010 |
Why?
|
| Syndrome | 3 | 1980 | 3251 | 0.010 |
Why?
|
| Corneal Ulcer | 1 | 1979 | 169 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1980 | 881 | 0.010 |
Why?
|
| Freezing | 1 | 1977 | 303 | 0.010 |
Why?
|
| Eye Protective Devices | 1 | 1996 | 33 | 0.010 |
Why?
|
| Mitosis | 1 | 1981 | 1208 | 0.010 |
Why?
|
| Retinal Vessels | 1 | 1981 | 772 | 0.010 |
Why?
|
| Organ Culture Techniques | 2 | 1988 | 813 | 0.010 |
Why?
|
| Cell Survival | 1 | 1985 | 5882 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1998 | 566 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2004 | 1640 | 0.010 |
Why?
|
| Complex Mixtures | 1 | 1994 | 28 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 1981 | 11483 | 0.010 |
Why?
|
| Glycoside Hydrolases | 1 | 1994 | 133 | 0.010 |
Why?
|
| Chondroitin Sulfates | 1 | 1994 | 187 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 19905 | 0.010 |
Why?
|
| Mice | 2 | 1995 | 81183 | 0.010 |
Why?
|
| Gentamicins | 1 | 1994 | 255 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1982 | 6386 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1982 | 2969 | 0.010 |
Why?
|
| Surface Properties | 1 | 1996 | 1184 | 0.010 |
Why?
|
| Cataract Extraction | 1 | 1977 | 481 | 0.010 |
Why?
|
| Neutrophils | 1 | 1985 | 3719 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 19229 | 0.010 |
Why?
|
| United States | 1 | 2020 | 69872 | 0.010 |
Why?
|
| Calcium | 1 | 1985 | 5756 | 0.010 |
Why?
|
| Aphakia, Postcataract | 1 | 1991 | 54 | 0.010 |
Why?
|
| Keratoplasty, Penetrating | 1 | 1991 | 155 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 21746 | 0.010 |
Why?
|
| Sphingomyelins | 1 | 1990 | 105 | 0.010 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 1991 | 84 | 0.010 |
Why?
|
| Lenses, Intraocular | 1 | 1991 | 140 | 0.010 |
Why?
|
| Glucose | 1 | 1981 | 4397 | 0.010 |
Why?
|
| Child, Preschool | 4 | 1995 | 41006 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1990 | 411 | 0.000 |
Why?
|
| Biopsy | 1 | 1979 | 6756 | 0.000 |
Why?
|
| Prognosis | 1 | 2007 | 29063 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1985 | 18029 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1982 | 21827 | 0.000 |
Why?
|
| Edema | 1 | 1987 | 789 | 0.000 |
Why?
|
| Neurons | 1 | 1981 | 9338 | 0.000 |
Why?
|
| Methylmethacrylates | 1 | 1980 | 72 | 0.000 |
Why?
|
| Fluoresceins | 1 | 1980 | 235 | 0.000 |
Why?
|
| Histological Techniques | 1 | 1980 | 198 | 0.000 |
Why?
|
| Leukocytes | 2 | 1978 | 2043 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1979 | 218 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1991 | 4397 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1984 | 2699 | 0.000 |
Why?
|
| Refractive Errors | 1 | 1978 | 142 | 0.000 |
Why?
|
| Risk Factors | 1 | 2004 | 72290 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1980 | 2505 | 0.000 |
Why?
|
| Strabismus | 1 | 1978 | 287 | 0.000 |
Why?
|
| Infant | 1 | 1995 | 35136 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1991 | 57776 | 0.000 |
Why?
|